You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKesson
Johnson and Johnson
Baxter
Boehringer Ingelheim

Last Updated: March 31, 2020

DrugPatentWatch Database Preview

OXYCODONE HYDROCHLORIDE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Oxycodone Hydrochloride, and when can generic versions of Oxycodone Hydrochloride launch?

Oxycodone Hydrochloride is a drug marketed by Ani Pharms Inc, Avanthi Inc, Genus Lifesciences, Lannett Co Inc, Mayne Pharma Inc, Novel Labs Inc, Abhai Llc, Alkem Labs Ltd, Ascent Pharms Inc, Eywa, Hi Tech, Hikma, Pharm Assoc, Specgx Llc, Vistapharm, Wockhardt Bio Ag, Actavis Elizabeth, Alvogen, Amneal Pharms, Aurolife Pharma Llc, Epic Pharma Llc, Nesher Pharms, Nuvo Pharm, Rhodes Pharms, Sun Pharm Inds Inc, Vintage Pharms, Barr Labs Inc, and Watson Labs. and is included in forty-eight NDAs.

The generic ingredient in OXYCODONE HYDROCHLORIDE is ibuprofen; oxycodone hydrochloride. There are sixty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ibuprofen; oxycodone hydrochloride profile page.

Drug patent expirations by year for OXYCODONE HYDROCHLORIDE
Recent Clinical Trials for OXYCODONE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Orthopedic Research and Education FoundationPhase 4
The George Washington University Biostatistics CenterPhase 3
The First Affiliated Hospital with Nanjing Medical UniversityN/A

See all OXYCODONE HYDROCHLORIDE clinical trials

Recent Litigation for OXYCODONE HYDROCHLORIDE

Identify potential future generic entrants

District Court Litigation
Case NameDate
INSPIRION DELIVERY SCIENCES, LLC v. TEVA PHARMACEUTICALS USA, INC.2019-04-19
Purdue Pharma L.P. v. Ascent Pharmaceuticals, Inc.2018-06-07
Purdue Pharma L.P. v. Ascent Pharmaceuticals, Inc.2018-01-11

See all OXYCODONE HYDROCHLORIDE litigation

PTAB Litigation
PetitionerDate
2018-02-28
2018-02-27
2016-05-11

See all OXYCODONE HYDROCHLORIDE litigation

Pharmacology for OXYCODONE HYDROCHLORIDE
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Synonyms for OXYCODONE HYDROCHLORIDE
(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
(5?)-4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one hydrochloride
(5alpha,17S)-14-hydroxy-3-methoxy-17-methyl-6-oxo-4,5-epoxymorphinan-17-ium chloride
124-90-3
14-Hydroxy-3-methoxy-17-methyl-4,5-epoxymorphinan-6-one--hydrogen chloride (1/1)
14-hydroxy-3-methoxy-17-methyl-4,5alpha-epoxymorphinan-6-one hydrochloride
14-Hydroxydihydrocodeinone hydrochloride
4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one hydrochloride
AKOS024457896
API0009028
C08026
CHEBI:7859
CHEMBL1200890
D00847
Dihydrone hydrochloride
Dihydrooxycodeinone hydrochloride
Dihydroxycodeinone hydrochloride
DTXSID80924674
FT-0673447
MUZQPDBAOYKNLO-RKXJKUSZSA-N
Oxecta (TN)
Oxycodone Hcl
Oxycodone hydrochloride (USP)
Oxycodone hydrochloride cii
Oxycodone hydrochloride solution, 1.0 mg/mL in methanol, analytical standard, for drug analysis
Oxycodone hydrochloride, analytical standard
Oxycodone hydrochloride, European Pharmacopoeia (EP) Reference Standard
Oxycodone hydrochloride, United States Pharmacopeia (USP) Reference Standard
oxycodone monohydrochloride
Oxycontin
Oxycontin (TN)
Q27107601
Roxicodone (TN)
SCHEMBL30095

US Patents and Regulatory Information for OXYCODONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 204021-001 Jun 12, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Actavis Elizabeth OXYCODONE HYDROCHLORIDE AND IBUPROFEN ibuprofen; oxycodone hydrochloride TABLET;ORAL 078769-001 Jan 4, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 203638-003 Jun 3, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Wockhardt Bio Ag OXYCODONE HYDROCHLORIDE oxycodone hydrochloride SOLUTION;ORAL 206456-001 Jun 16, 2015 AA RX No No   Start Trial   Start Trial   Start Trial
Rhodes Pharms OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 091490-005 Mar 9, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Avanthi Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 091393-001 Aug 31, 2009 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKesson
Johnson and Johnson
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.